한빛사
>
한빛사논문
한빛사논문
- 조회625
Ophthalmology, Mar 22 2024, S0161-6420(24)00198-2 | https://doi.org/10.1016/j.ophtha.2024.03.017
Incident non-infectious uveitis risk after immune checkpoint inhibitor treatment
Myung Soo Chang MD 1,#, Seung Won Lee MD, PhD 2,#, Sunyeup Kim 3, Christopher Seungkyu Lee MD, PhD 1, Suk Ho Byeon MD, PhD 1, Sung Soo Kim MD, PhD 1, Yong Joon Kim MD, PhD 1
1Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea
2Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, Korea
3Department of Medical AI, Sungkyunkwan University School of Medicine, Suwon, Korea
#Joint first authors
Corresponding author: Yong Joon Kim, MD, PhD
Abstract
Our findings suggest that, while incident uveitis is rare in patients with cancer treated with anti-PD-1/PD-L1 inhibitors, there is an increased risk in those with skin melanoma, warranting vigilant monitoring for uveitis in this subgroup.
논문정보
- Reports
- 2024년 03월 (BRIC 등록일 2024-03-25)
- 국내 연구진
- 의약학 > 분자세포의학
댓글 작성 로그인
팝업 닫기관련 링크
연구자 키워드
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기
